Panelist: Kai Langel Director, R&D Operations Innovation Janssen Clinical Innovation
Panelist: Tero Laulajainen VP - Head Global Clinical Science and Operations UCB
Panelist: Anne Marie Inglis Senior Director, Clinical Operations Mallinckrodt Pharmaceuticals
Head of Operations
PPD Digital PPD
Panelist: Rasmus Hogreffe VP Decentralized Clinical Trial Innovations Medable
Moderator: Alison Holland Head of Decentralized Clinical Trials Medable
With more patients currently at home than in sites, the clinical paradigm has permanently shifted towards remote and virtual approaches. And while remote data capture and trial decentralization are mission critical to study success, barriers still exist to their implementation:
Can we decentralize studies into therapies with higher toxicity profiles, such as those in oncology?
How do we ensure older participants are able to successfully use eCOA and DCT technologies?
Can we use a remote eCOA and DCT approach without the reliance on multiple vendors and disjointed solutions?
To overcome these hurdles, flexible Electronic Clinical Outcome Assessment (eCOA) technologies with native DCT capabilities like TeleVisits, will be essential tools in maintaining data quality with fewer deviations and missed appointments.
Join clinical trial leaders as we explore common barriers to adopting eCOA and DCT approaches. In this webinar you’ll learn: